Domokos Mathe

Dr. Domokos Mathe

Department of Biophysics and Radiation Biology, Nanobiotechnology and In Vivo Imaging Centre, Semmelweis University, Tűzoltó utca 37-47, 1094 Budapest, Hungary
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ECEszter Császár
Eszter Császár
NLNikolett Lénárt
Nikolett Lénárt
CCCsaba Cserép
Csaba Cserép
KZKörnyei Zsuzsanna
Környei Zsuzsanna
RFRebeka Fekete
Rebeka Fekete
ÁDÁdám Dénes
Ádám Dénes
Microglia, the main immunocompetent cells of the brain, regulate neuronal function, but their contribution to cerebral blood flow (CBF) regulation has remained elusive. Here, we identify microglia as important modulators of CBF both under physiological conditions and during hypoperfusion. Microglia establish direct, dynamic purinergic contacts with cells in the neurovascular unit that shape CBF in both mice and humans. Surprisingly, the absence of microglia or blockade of microglial P2Y12 receptor (P2Y12R) substantially impairs neurovascular coupling in mice, which is reiterated by chemogenetically induced microglial dysfunction associated with impaired ATP sensitivity. Hypercapnia induces rapid microglial calcium changes, P2Y12R-mediated formation of perivascular phylopodia, and microglial adenosine production, while depletion of microglia reduces brain pH and impairs hypercapnia-induced vasodilation. Microglial actions modulate vascular cyclic GMP levels but are partially independent of nitric oxide. Finally, microglial dysfunction markedly impairs P2Y12R-mediated cerebrovascular adaptation to common carotid artery occlusion resulting in hypoperfusion. Thus, our data reveal a previously unrecognized role for microglia in CBF regulation, with broad implications for common neurological diseases.

22 October 2013 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
LCLídia Cunha
Lídia Cunha
IHIldiko Horvath
Ildiko Horvath
SFSara Ferreira
Sara Ferreira
JLJoana Lemos
Joana Lemos
PCPedro Costa
Pedro Costa
LMLuís F. Metello
Luís F. Metello

29 October 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Open access
LBLajos Balogh
Lajos Balogh
APAndras Polyak
Andras Polyak
DMDomokos Mathe
Domokos Mathe
RKReka Kiraly
Reka Kiraly
JTJuliana Thuroczy
Juliana Thuroczy
ASAlexander Schauss
Alexander Schauss
The purpose of this study was to determine the absorption, distribution and excretion of 99mtechnetium-labeled, high-molecular-weight hyaluronan ((99mTc-HA) and 99mtechnetium pertechnetate (99mTc-P) after single dose, oral administration to Wistar rats and Beagle dogs. A pilot study utilized 99mTc-HA alone, and a second confirmatory study compared uptake of labeled 99mTc-HA with 99mTc-P. Urinary and fecal excretion after 99mTc-HA ingestion by rats showed 86.7−95.6% of radioactivity was recovered, almost all in feces. All tissues examined showed incorporation of radioactivity from 99mTc-HA starting at 15 min and persisting for 48 h, in a pattern significantly different from 99mTc-P. Whole-body scintigraphs and close-ups of the ventral chest region showed nonalimentary radioactivity from 99mTc-HA concentrated in joints, vertebrae and salivary glands four hours after administration. Autoradiography of skin, bone and joint tissue pieces after 24 h showed incorporation of radioactivity from 99mTc-HA, but not from 99mTc-P. Conversely, absorption, distribution and excretion of 99mTc was completely different from 99mTc-HA, showing an expected pattern of rapid absorption and excretion in urine, with accumulation in thyroid glands, stomach, kidney and bladder. This report presents the first evidence for uptake and distribution to connective tissues of orally administered, high-molecular-weight HA.

1 June 2016 in Cancer Biotherapy and Radiopharmaceuticals
Verified
Journal Article
Closed access
Zoltan VargaZoltan Varga
Zoltan Varga
IGIstván Gyurkó
István Gyurkó
KPKrisztina Pálóczi
Krisztina Pálóczi
EBEdit I. Buzás
Edit I. Buzás
IHIldikó Horváth
Ildikó Horváth
KSKrisztián Szigeti
Krisztián Szigeti
The biodistribution of extracellular vesicles (EVs) is a fundamental question in the field of circulating biomarkers, which has recently gained attention. Despite the capabilities of nuclear imaging methods, such as single-photon emission computed tomography, radioisotope labeling of EVs and the use of the aforementioned methods for in vivo studies hardly can be found in the literature. In this article, the authors describe a novel method for the radioisotope labeling of erythrocyte-derived EVs using the 99mTc-tricarbonyl complex. Moreover, the capability of the developed labeling method for in vivo biodistribution studies is demonstrated in a mouse model. The authors found that the intravenously administered 99mTc-labeled EVs mostly accumulated in the liver and spleen. The in vivo stability of the labeled EVs was assessed by the comparison of the obtained biodistribution of EVs with that of the free 99mTc-tricarbonyl. According to the authors' data, only a minor fraction of the radioactive label became detached from the EVs.

1 July 2014 in Biomaterials
Verified
Journal Article
Open access
XCXianjin Cui
Xianjin Cui
SBSalome Belo
Salome Belo
DKDirk Krüger
Dirk Krüger
YYYong Yan
Yong Yan
RRRafael T.M. de Rosales
Rafael T.M. de Rosales
PBPhil Blower
Phil Blower
Magnetic nanoparticles (NPs) MnFe2O4 and Fe3O4 were stabilised by depositing an Al(OH)3 layer via a hydrolysis process. The particles displayed excellent colloidal stability in water and a high affinity to [(18)F]-fluoride and bisphosphonate groups. A high radiolabeling efficiency, 97% for (18)F-fluoride and 100% for (64)Cu-bisphosphonate conjugate, was achieved by simply incubating NPs with radioactivity solution at room temperature for 5 min. The properties of particles were strongly dependant on the thickness and hardness of the Al(OH)3 layer which could in turn be controlled by the hydrolysis method. The application of these Al(OH)3 coated magnetic NPs in molecular imaging has been further explored. The results demonstrated that these NPs are potential candidates as dual modal probes for MR and PET. In vivo PET imaging showed a slow release of (18)F from NPs, but no sign of efflux of (64)Cu.

7 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NMNicola Mitwasi
Nicola Mitwasi
AFAnja Feldmann
Anja Feldmann
CAClaudia Arndt
Claudia Arndt
SKStefanie Koristka
Stefanie Koristka
NBNicole Berndt
Nicole Berndt
MBMichael Bachmann
Michael Bachmann
Antigen-specific redirection of immune effector cells with chimeric antigen receptors (CARs) demonstrated high therapeutic potential for targeting cancers of different origins. Beside CAR-T cells, natural killer (NK) cells represent promising alternative effectors that can be combined with CAR technology. Unlike T cells, primary NK cells and the NK cell line NK-92 can be applied as allogeneic off-the-shelf products with a reduced risk of toxicities. We previously established a modular universal CAR (UniCAR) platform which consists of UniCAR-expressing immune cells that cannot recognize target antigens directly but are redirected by a tumour-specific target module (TM). The TM contains an antigen-binding moiety fused to a peptide epitope which is recognized by the UniCAR molecule, thereby allowing an on/off switch of CAR activity, and facilitating flexible targeting of various tumour antigens depending on the presence and specificity of the TM. Here, we provide proof of concept that it is feasible to generate a universal off-the-shelf cellular therapeutic based on UniCAR NK-92 cells targeted to tumours expressing the disialoganglioside GD2 by GD2-specific TMs that are either based on an antibody-derived single-chain fragment variable (scFv) or an IgG4 backbone. Redirected UniCAR NK-92 cells induced specific killing of GD2-expressing cells in vitro and in vivo, associated with enhanced production of interferon-γ. Analysis of radiolabelled proteins demonstrated that the IgG4-based format increased the in vivo half-life of the TM markedly in comparison to the scFv-based molecule. In summary, UniCAR NK-92 cells represent a universal off-the-shelf platform that is highly effective and flexible, allowing the use of different TM formats for specific tumour targeting.